HHS Announces $90M Partnership For Anti-Bioterrorism Drug
The U.S. Department of Health and Human Services will provide up to $90 million through a public-private partnership with a unit of The Medicines Co. for the development of a drug...To view the full article, register now.
Already a subscriber? Click here to view full article